Description
Japan Conjugate Vaccine Market:
Conjugate Vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached to a protein to enhance immunogenicity and protects against invasive diseases. Japan is one of the most prominent markets of conjugate vaccines.
Japan, at 84 years, has one of the highest life expectancies in the world. Currently, both PPSV–23 and PCV–13 are available for the elderly for the prevention of Streptococcus pneumoniae -related diseases. Despite these two vaccines being made available for the elderly, the national immunization program launched for these aged 65 and older as on October 1, 2014, only subsidized PPSV–23. Japan has frequently reported low incidence of Meningococcal disease, and therefore the disease is not considered a high health care priority.
Market Segmentation:
Based on disease indication, the market is segmented into:
o Pneumococcal
o Haemophilus influenza type b
o Diphtheria-tetanus-pertussis
o Meningococcal
o Others
Based on end user, the market is segmented into:
o Paediatric
o Adult
Key growth factors:
Japan is projected to be a stable market for conjugate vaccines during the forecast period. Rapidly increasing geriatric population, rise in consumer awareness, growing disposable income and healthcare expenditure and modernization of healthcare infrastructure will drive the Japan market for conjugate vaccines. Japan, with the highest life expectancy out of all other countries in the world, has its old population creating demand for adult conjugate vaccines.
Threats and key players:
1. Although the health situation in Japan is among the best in the world, there is still a significant gap to be filled, with regard to the use of vaccines to prevent severe infections. This gap has major implications for public health, both in Japan and other countries since Japan is cited as a source for infectious diseases to countries that have those diseases under better control through vaccination. There is also a need to organize an efficient immunization program, due to the limited resources for health care. Under-reporting, lack of awareness and focus on meningococcal disease are some of the major threats.
2. Major conjugate vaccine providers are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.
What’s covered in the report?
1. Overview of the Japan conjugate vaccine market
2. Market drivers and challenges in the Japan conjugate vaccine market
3. Market trends in the Japan conjugate vaccine market
4. Historical, current and forecasted market size data for Japan based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) – by revenue and by volume
5. Historical, current and forecasted market size data for Japan based on end user (paediatric and adult conjugate vaccines) – by revenue and by volume
6. Analysis of the competitive landscape and profiles of major companies operating in the Japan market
Why buy?
o Understand the demand for conjugate vaccines to determine the viability of the market
o Develop strategies based on the drivers and trends for each of the segments
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed
o Recognize the key competitors of this market and respond accordingly
o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth
o Define the competitive positioning by comparing the products and services with the key players in the market
Chapter 1: Executive Summary
1.1 Market Scope and Segmentation
1.2 Key Questions Answered in This Study
1.3 Executive Summary I
1.4 Executive Summary II
Chapter 2: Introduction
2.1. Blockchain technology-Functionality
2.2. Blockchain Application
2.3. Blockchain use cases
2.4. Value chain-Blockchain technology market
Chapter 3: Global Blockchain Technology Market overview
3.1. Overview – key observations, historical (2016-2017) and forecasted (2018-2023) market size (USD bn), geography wise market size (USD bn) in 2017
3.2. Market adoption
3.3. Market trends
Chapter 4: Blockchain Technology Market regional market overview
4.1. North America- Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.2. Europe– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.3. Asia Pacific– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.4. Latin America– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
4.5. Middle East & Africa– Historical (2016-2017) and forecasted (2018-2023) market size (USD Bn), drivers, trends and challenges
Chapter 5: Blockchain Technology Market segmentation by industries
5.1. Global industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Industry overview, market share
5.1.1. North America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.2. Europe industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.3. Asia Pacific industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.4. Latin America industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
5.1.5. Middle East & Africa industry segmentation by BFS, Insurance, Supply Chain, Healthcare and other industries – Revenue contribution (historical and forecasted), drivers, and key competitors
Chapter 6: Blockchain Technology Market segmentation by type – Private, public and mixed
6.1. Market overview by type – revenue contribution, market growth, influential factors, adoption
Chapter 7: Patent Analysis
7.1. Patent Overview
7.2. Patents Filed/ Published (2012 – 2016)
7.3. Patents by Major Companies
7.4. Patents by Geographical Origin
7.5. Patents by Platform
7.6. Patents by Ledger Types
7.7. Patents by Authentication
7.8. Patents by Application types
Chapter 8: Company Profiles
8.1. Microsoft Corporation
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.2. IBM
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.3. Accenture
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.4. Deloitte
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.5. Capgemini
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.6. Cognizant
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.7. Infosys
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.8. Tata Communication Services
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.9. VirtusaPolaris
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
8.10. Wipro
o Company Snapshot
o Key People
o Financial Standing
o Blockchain Offering
o Focus Area
o Recent Initiatives
o Key Verticals
o Geographical Presence
Chapter 9: Start-up Company Overview
9.1. Chain (*)
o Overview
o Key People
o Investor
o Client/Partners
o Recent Initiatives
(*) similar information is provided for all the below companies
9.2. Consensys
9.3. R3 CEV
9.4. Ripple
9.5. Guardtime
9.6. Gem
9.7. Everledger
9.8. Ascribe
Chapter 10: Conclusion
10.1. Blockchain Opportunity
10.2. Conclusion
Chapter 11: Appendix
11.1. List of Tables
11.2. Research Methodology
11.3. Assumptions
11.4. About Netscribes Inc.
